News » MHRA alert » Alert: fingolimod hydrochloride
August 20th 2024
Glenmark Pharmaceuticals Europe Ltd is recalling four batches of fingolimod hydrochloride as a precaution after testing showed variability of the capsule contents beyond permitted levels.
The affected batches are:
| Batch No | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 1306526 | 31-May-2025 | 28 | 17-Oct-2023 |
| 1306528 | 31-May-2025 | 28 | 06-Feb-2024 |
| 1400709 | 30-Nov-2025 | 28 | 27-Feb-2024 |
| 1400710 | 30-Nov-2025 | 28 | 15-Mar-2024 |
Healthcare professionals are asked to quarantine all remaining stock and return it to your supplier using your supplier’s approved process. No further action is required by patients
For medical information enquiries please use the following options: by phone +44 8004 580 383 or email medical_information@glenmarkpharma.com
For stock control enquiries please email orders.uk@glenmarkpharma.com
